TAE LIFE SCIENCES

Investors & News

2019 | Physics World

Boron Neutron Capture Therapy Progresses Towards Clinical Cancer Treatments

The main obstacle to BNCT has been that a nuclear reactor was required to generate the neutron beams needed for treatments. To overcome this problem, TAE Life Sciences is developing an accelerator-based neutron source. “We have created a low-energy neutron beam source that is reliable, compact and can be installed in a hospital facility,” says Bruce Bauer, CEO of TAE Life Sciences. “This changes the game on BNCT.”

2019 | PR Newswire

TAE Life Sciences Adds Seasoned Chief Operating Officer to Scale New Radiation Treatment Platform

Robert Hill brings expertise in the technical and clinical development of radiation systems to speed platform research and commercialization.

TLS in the News

Events

New TAE Unit Launched To Treat Cancers Gains $40M In Financing And Closes Partnership Deal

New TAE Unit Launched To Treat Cancers Gains $40M In Financing And Closes Partnership Deal

BNCT may provide a new option for patients with GBM and head and neck cancers due to its ability to leave healthy tissue unharmed.

TAE Life Sciences Inks $40M Series A Funding

TAE Life Sciences Inks $40M Series A Funding

TAE Life Sciences, a medical technology company developing an accelerator-based platform for clinical investigation of a promising, previously inaccessible cancer treatment, made its public debut today.

TAE Life Sciences Raises $40M For Neutron Beam Cancer Treatment

TAE Life Sciences Raises $40M For Neutron Beam Cancer Treatment

TAE Life Sciences said yesterday it raised $40 million in venture capital to support the development of its neutron beam technology designed as a potential treatment for head and neck, glioblastoma multiforme and other cancers.

TAE Raises $40M To Develop New Targeted Radiotherapy

TAE Raises $40M To Develop New Targeted Radiotherapy

Medtech firm TAE Life Sciences is developing a ground-breaking radiotherapy technology which will be able to treat hard-to-reach cancers with targeted beams.

$40 Million for Boron Neutron Capture Therapy

$40 Million for Boron Neutron Capture Therapy

TAE Life Sciences aims to commercialize a cancer radiation treatment called Boron Neutron Capture Therapy. In BNCT, boron-10 is administered to tumors, irradiated with a beam of neutrons, and broken down into charged particles that kill cancer cells.

A Surprise Application To Cancer

A Surprise Application To Cancer

There’s a radiological medical technique called Boron Neutron Capture Therapy (BNCT), which is like a very targeted chemotherapy.

TAE Life Sciences Is Trying To Make Boron Neutron Capture Therapy More Accessible

TAE Life Sciences Is Trying To Make Boron Neutron Capture Therapy More Accessible

The neutron beam is aimed at the cancer patient’s tumors for about 30 minutes, and is combined with a boron-based substance that is injected into the patient intravenously and accumulates in the cancer cells.

TAE Life Sciences Announces $40 Million In Venture Capital

TAE Life Sciences Announces $40 Million In Venture Capital

BNCT is a particularly promising technique for treating cancers of the head and neck region that are difficult or impossible to treat using other types of therapy. The procedure has already been tested in Japan, the United States and other locales.

TAE Life Sciences to Develop Groundbreaking Therapy for Difficult-to-Treat Cancers, including Head, Neck and GBM; Announces $40 Million Series A Funding

TAE Life Sciences to Develop Groundbreaking Therapy for Difficult-to-Treat Cancers, including Head, Neck and GBM; Announces $40 Million Series A Funding

TAE Life Sciences is the first to license TAE Technologies’ accelerator-based neutron beam technology for clinical investigation of Boron Neutron Capture Therapy (BNCT).

International Society for Neutron Capture Therapy (ISNCT)

International Society for Neutron Capture Therapy (ISNCT)

September 13-18, 2020

Granada, Spain
JASTRO 2020

JASTRO 2020

October 1-3, 2020

Sapporo, Japan
ASTRO Annual Meeting 2020

ASTRO Annual Meeting 2020

October 25-28, 2020

Miami Beach, FL